openPR Logo
Press release

Viscosupplementation Market Set to Witness an Uptick during 2016-2023

12-19-2017 07:14 AM CET | Health & Medicine

Press release from: Transparency Market Research

Viscosupplementation Market Set to Witness an Uptick during

Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of the extracellular matrix as it contributes significantly to migration and cell proliferation. Hyaluronic acid acts as a joint lubricant and elastic in nature that allows it to act as a shock absorber because of its viscous nature. Chemical modification allows Hyaluronic acid to transform into several physical forms such as soft or stiff hydrogels, non-woven meshes, flexible sheets, viscoelastic solutions, electrospun fibers, macroporous, fibrillar sponges, and nanoparticulate fluids for use in a range of preclinical and clinical applications. According to the WHO, osteoarthritis is a degenerative joint disease that mainly affects the articular cartilage and is related with aging. This condition affects the joints that have been continually stressed over the years including the hips, fingers, lower spine and knees. According to the WHO, globally, around 9.6% men and 18.0% women are above the age of 60 years and suffer from symptomatic osteoarthritis, which is one of the top disabling diseases in developed countries. Osteoarthritis is mostly classified in two types: primary and secondary where primary osteoarthritis occurs due to aging and wear and tear of joints and secondary osteoarthritis occurs due to an accident or obesity at an early stage.

Report Overview and TOC @ https://www.transparencymarketresearch.com/viscosupplementation-market.html

Factors driving the growth of viscosupplementation market are increasing geriatric population, increasing demand for minimally invasive surgical procedures, high patient awareness about new drugs and devices for the treatment of osteoarthritis and rising obese population globally. However, lack of safety and inefficiency of the products might hamper the market growth. The product innovation and process development is an opportunity window for market players as safety and efficacy are the major concerns of viscosupplementation products. Thus, introduction of products that helps to overcome these concerns have an opportunity to enter and establish in the global viscosupplementation market.

The FDA approved hyaluronates currently available in the viscosupplementation market are Hyalgan (Sanofi), Euflexxa (Ferring Pharmaceuticals, Inc.), Orthovisc (Anika Therapeutics), Supartz and Gel-One (Seikagaku Corporation), and Synvisc, Synvisc One (Genzyme) and Durolane (Q MED AB).

Request for Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10232

North America is the largest viscosupplementation market globally accounting for high product demand, high awareness in the region and acceptance of high priced products. Europe experienced an economic downturn that created problem in the hyaluronic acid products market as reimbursement policies turned out to be difficult but still the premium priced products were accepted in some of the countries. Although European market is expected to review and provide essential opportunity for viscosupplementation products as the economical conditions are reviving. Asia-Pacific and RoW observed to be the emerging markets for viscosupplementation and Asia-Pacific viscosupplementation market is especially driven by economic development, healthcare facility enhancements and high demand for minimally invasive surgeries.

Some of the key players of viscosupplementation market are Alcon, Inc., F. Hoffmann-La Roche Ltd., Allergan, Inc., Fidia Farmaceutici SpA, Anika Therapeutics, Inc., Ferring Pharmaceuticals, Inc., GALDERMA S.A., LifeCore Biomedical LLC, Hyaltech Ltd. and others.

Pre Book Full Report @ https://www.transparencymarketresearch.com/viscosupplementation-market.html?secure=NTIxNS41&type=PB

ABOUT US:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

CONTACT:
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-345

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viscosupplementation Market Set to Witness an Uptick during 2016-2023 here

News-ID: 866479 • Views: 128

More Releases from Transparency Market Research

Skincare Packaging Market Historical Analysis 2013–2018 with Opportunity Asses …
The global skincare packaging market is analysed by Transparency Market Research to find opportunities and analyse future trends. The report titled “Skincare Packaging Market: Global Industry Analysis, 2013 – 2018 and Opportunity Assessment, 2019 – 2027” states that the increased premiumization of skincare products and advancement in printing technology is propelling the growth of global skincare packaging market. The global skincare packaging market is projected to expand at a CAGR
HAZMAT Packaging Market is projected to expand at a CAGR of 5.8% | Leading Playe …
The global HAZMAT packaging market was valued at US$ 8.10 Billion in 2018 and is projected to expand at a CAGR of 5.8%, during the forecast period. Vendor Landscape Remains Highly Splintered in the Global Hazmat Packaging Market The key manufacturers in the HAZMAT packaging market profiled in this report include– Greif Inc., SIA Flexitanks, Hoover Ferguson Group, Schutz Container Systems, Inc., Mauser Group B.V., HINRICH Industries, Thielmann US LLC, Eagle Manufacturing
Aseptic Paper Packaging for Flat Top Carton Market is anticipated to grow at a C …
The global aseptic paper packaging for flat top carton market is estimated to be valued at US$ 7,030.0 Mn in 2019 and is anticipated to grow at a CAGR of 5.5%, to reach a market size of US$ 10,766.1 Mn by the end of the forecast period. Aseptic paper packaging for flat top carton is a paper packaging type used for manufacturing flat top carton which are also known as UHT
Global Magnesium Gluconate Market Current And Projected Industry Size In Terms O …
Magnesium sulfate is the magnesium salt of gluconic acid. Magnesium gluconate is an organic compound having chemical formula C12H22MgO14. Magnesium gluconate is a tasteless, odorless and non-flammable white solid. Magnesium is an important mineral which plays essential roles for many systems in human body, particularly in muscle, nervous system, and cellular function. Magnesium gluconate is a suitable alternative which would be used as supplement to maintain the level of magnesium

All 5 Releases


More Releases for Viscosupplementation

Global Viscosupplementation - Analysis and Market Forecasts
"The Report MediPoint: Viscosupplementation - Global Analysis and Market Forecasts provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Viscosupplementation Market Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability across the globe. Intra-articular viscosupplementation with hyaluronic acid (HA) has become an increasingly accepted therapeutic alternative to knee replacement surgery in the
Viscosupplementation Market - Global Industry Analysis 2025
Viscosupplementation is a treatment that helps reduce the joint pain and improves the functional condition of the osteoarthritic joint. It involves the injection of a thick fluid called hyaluronate into the knee. Hyaluronic acid is found in the viscous synovial fluid that lubricates the cartilage surfaces and protects the joints from shock. This acid is an elastic substance that is naturally secreted by mesothelial cells. Osteoarthritis—the most common type of
Viscosupplementation Market : Analysis and Forecast by 2023
Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of
Look Inside Viscosupplementation Market - Growth after 2017
Qyresearchreports include new market research report Global Viscosupplementation Sales Market Report 2017 to its huge collection of research reports. This report on the global Viscosupplementation market has been curated by research analysts of the industry, with a chief aim to put forth the current market conditions for the global Viscosupplementation. Its objective is to shed light on the prospects of growth of the market and reach out to a wide range
Viscosupplementation Market | Analysis & Key Trends 2023
Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of
Viscosupplementation Devices – Medical Devices Pipeline Assessment, 2017
ReportBazzar has released its latest research-based report entitled ‘Viscosupplementation’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Viscosupplementation market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Viscosupplementation market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact